Brochure: Capsugel® R&D portfolio
Posted: 5 May 2020 | Capsugel® | Lonza | No comments yet
The Capsugel® R&D portfolio features capsule and related service solutions for faster research and development during pre-clinical and clinical stages.
The process of bringing a medicine to market takes an average of 13 years from initial discovery through clinical testing phases and ultimately to market availability. We provide an integrated product research and development approach from feasibility assessment through clinical trials for pharmaceutical and nutraceuticals customers. As a comprehensive solutions provider, our customers look to us for all of their clinical trial material and service needs.
Related content from this organisation
Related topics
Biopharmaceuticals, Drug Delivery Systems, Formulation, Research & Development (R&D)